MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Charles River Laboratories International Total Current Liabilities 2011-2026 | CRL
Annual Total Current Liabilities Charles River Laboratories International
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 994 M | 1.06 B | 1.09 B | 1.03 B | 840 M | 710 M | 558 M | 464 M | 430 M | 312 M | 296 M | 247 M | 342 M | 217 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.09 B | 217 M | 614 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 29.8 | -3.87 % | $ 321 M |  China |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
5.75 M | - | - | $ 79.8 M | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.13 | -3.54 % | $ 1.44 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | - | - | $ 914 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
6.8 B | $ 219.93 | 0.09 % | $ 161 B | USA |
 |
Celcuity
CELC
|
31.7 M | $ 104.25 | 0.08 % | $ 4.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
1.56 B | - | - | $ 26.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 209.75 | 2.09 % | $ 23.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
78.1 M | $ 19.51 | -5.18 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 11.07 | 1.37 % | $ 314 M | Israel |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Exact Sciences Corporation
EXAS
|
732 M | $ 103.42 | - | $ 19.2 B | USA |
 |
Interpace Biosciences
IDXG
|
10.6 M | $ 1.82 | - | $ 7.98 M | USA |
 |
Lantheus Holdings
LNTH
|
241 M | $ 67.04 | - | $ 4.64 B | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 23.02 | - | $ 696 M | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | - | -0.62 % | $ 28.7 B |  Schweiz |
 |
Guardant Health
GH
|
226 M | $ 106.6 | 1.65 % | $ 13.1 B | USA |
 |
NeoGenomics
NEO
|
301 M | $ 11.47 | - | $ 1.45 B | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B |  Niderland |
 |
Natera
NTRA
|
310 M | - | -0.5 % | $ 20.7 B | USA |
 |
OPKO Health
OPK
|
193 M | $ 1.25 | 2.05 % | $ 868 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
IDEXX Laboratories
IDXX
|
1.07 B | - | - | $ 53.5 B | USA |
 |
Illumina
ILMN
|
1.55 B | $ 117.01 | -1.95 % | $ 18.6 B | USA |
 |
IQVIA Holdings
IQV
|
6.96 B | $ 176.27 | - | $ 32 B | USA |
|
Biodesix
BDSX
|
14.3 M | - | - | $ 1.33 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 289.4 | 1.75 % | $ 24.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
605 K | $ 3.56 | -4.56 % | $ 1.91 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | - | - | $ 11 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
337 M | - | -3.13 % | $ 1.19 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.23 | - | $ 5.12 M | USA |
 |
Bioventus
BVS
|
175 M | $ 8.04 | - | $ 504 M | USA |